1. Home
  2. CXDO vs SAVA Comparison

CXDO vs SAVA Comparison

Compare CXDO & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXDO
  • SAVA
  • Stock Information
  • Founded
  • CXDO 1995
  • SAVA 1998
  • Country
  • CXDO United States
  • SAVA United States
  • Employees
  • CXDO 185
  • SAVA N/A
  • Industry
  • CXDO Telecommunications Equipment
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CXDO Telecommunications
  • SAVA Health Care
  • Exchange
  • CXDO Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • CXDO 196.8M
  • SAVA 213.0M
  • IPO Year
  • CXDO 1998
  • SAVA N/A
  • Fundamental
  • Price
  • CXDO $6.25
  • SAVA $3.42
  • Analyst Decision
  • CXDO Strong Buy
  • SAVA Buy
  • Analyst Count
  • CXDO 4
  • SAVA 2
  • Target Price
  • CXDO $8.75
  • SAVA $5.00
  • AVG Volume (30 Days)
  • CXDO 81.8K
  • SAVA 2.8M
  • Earning Date
  • CXDO 11-04-2025
  • SAVA 11-07-2025
  • Dividend Yield
  • CXDO N/A
  • SAVA N/A
  • EPS Growth
  • CXDO 13.31
  • SAVA N/A
  • EPS
  • CXDO 0.11
  • SAVA N/A
  • Revenue
  • CXDO $64,476,000.00
  • SAVA N/A
  • Revenue This Year
  • CXDO $13.46
  • SAVA N/A
  • Revenue Next Year
  • CXDO $11.27
  • SAVA N/A
  • P/E Ratio
  • CXDO $56.98
  • SAVA N/A
  • Revenue Growth
  • CXDO 13.10
  • SAVA N/A
  • 52 Week Low
  • CXDO $3.75
  • SAVA $1.15
  • 52 Week High
  • CXDO $7.34
  • SAVA $33.98
  • Technical
  • Relative Strength Index (RSI)
  • CXDO 48.35
  • SAVA 46.21
  • Support Level
  • CXDO $6.00
  • SAVA $3.62
  • Resistance Level
  • CXDO $6.29
  • SAVA $4.01
  • Average True Range (ATR)
  • CXDO 0.23
  • SAVA 0.37
  • MACD
  • CXDO 0.02
  • SAVA -0.14
  • Stochastic Oscillator
  • CXDO 59.09
  • SAVA 4.29

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: